Bone scan in haemodialysis patients: relation to hyperparathyroidism and aluminium toxicity. 1985

C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen

The influence of hyperparathyroidism and aluminium toxicity on bone scan scores (FS = Fogelman's score) was studied in 37 haemodialysis patients (group 1), of whom 24 had aluminium toxicity (group 2). FS, parathormone (iPTH) and aluminium status were assessed simultaneously, the latter by measuring serum aluminium before (BAl) and 48 hours after (PAl) a desferrioxamine infusion. FS correlated directly with iPTH in all groups, inversely with PAl and DAl (= PAl - BAl) in group 1; FS less than or equal to 2 was found in group 2 only (2 alpha less than 0.05). The time course of FS and aluminium concentration was also studied in 24 patients: a PAl increase was significantly associated with a FS decrease (2 alpha less than 0.001). In conclusion, hyperparathyroidism increases and aluminium toxicity decreases FS; FS less than or equal to 2 is very suggestive of aluminium toxicity.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
January 1984, Mineral and electrolyte metabolism,
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
June 1985, British medical journal (Clinical research ed.),
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
June 1985, British medical journal (Clinical research ed.),
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
April 1978, British medical journal,
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
July 1989, Lancet (London, England),
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
August 1987, Lancet (London, England),
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
January 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress,
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
December 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
October 1993, Zhonghua yi xue za zhi,
C Tielemans, and R Wens, and F Collart, and M Dratwa, and J Smeyers-Verbeke, and I Van Hooff, and G De Roy, and P Bergmann, and D Verbeelen
October 2008, The Indian journal of medical research,
Copied contents to your clipboard!